Cargando…
Antitumour Organometallics. III. In Vivo Activity of Diphenylantimony(III) and Diorganotin(IV) Dithiophosphorus Derivatives Against P388 Leukemia
Diphenylantimony(III) and diorganotin(IV) derivatives of dithiophosphorus ligands, i.e. Ph(2)SbS(2)PR′(2) (R′ = Ph, OPr-i) and R(2)Sn(S(2)PR′(2))(2) (R = n-Bu, Ph, R′ = Ph; R = Ph, R′ = OPr-i), have been screened against P388 leukemia in mice. All the compounds showed marginal activity towards this...
Autores principales: | Keppler, Bernhard K., Silvestru, Cristian, Haiduc, Ionel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364873/ https://www.ncbi.nlm.nih.gov/pubmed/18476218 http://dx.doi.org/10.1155/MBD.1994.73 |
Ejemplares similares
-
Antitumor Organometallics. IV. The Mutagenic Potential of Some
Diphenylantimony(III) Dithiophosphorus Derivatives
por: Socaciu, Carmen, et al.
Publicado: (1994) -
Substitutional disorder in a hypervalent diorganotin(IV) dihalide
por: Rotar, Adina, et al.
Publicado: (2007) -
Protein-binding Properties of two Antitumour Ru(III) Complexes to
Human Apotransferrin and Apolactoferrin
por: Kratz, F., et al.
Publicado: (1994) -
Diorganotin Complexes of a Thiosemicarbazone, Synthesis: Properties, X-Ray Crystal Structure, and Antiproliferative Activity of Diorganotin Complexes
por: Wiecek, Joanna, et al.
Publicado: (2010) -
Genotoxicity of Some Metal-Based Antineoplastics, Evaluated by SOS Chromotest and Cytogenetic Analysis
por: Socaciu, Carmen, et al.
Publicado: (1996)